CSI Market
Sign In | Register

Johnson and Johnson (JNJ) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access JNJ Annual Cash Flow →
The quarterly cash flow data below helps track how Johnson and Johnson's liquidity profile has evolved over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 28 2026)
6 Months 		(Mar 29 2026) (Dec 28 2025) (Sep 28 2025) (Jun 29 2025)
Operating Activities
Income10,769.00
Depreciation & amortization3,963.00
Amortization of Other Assets2,500.00
Minority interests0.00
Asset Impairment Charges286.00
Provision For Loan Losses Expensed-12.00
Increase (Decrease) in Inventories1,002.00
Purchased in-process R&D0.00
Gain (Loss) on Sale of Assets and Asset Impairment Charges43.00
Share-based Compensation758.00
Stock based compensation0.00
Taxes paid on sales of businesses0.00
Treasury Stock Issued For Employee Compensation And Stock Option Plans Net Of Cash Proceeds-
Stock Issued During Period Value Conversion Of Convertible Securities-
Noncash Or Part Noncash Acquisition Value Of Assets Acquired-
In Process Research And Development Charge2.00
Income taxes0.00
Gain (Loss) on Sale of Equity Investments0.00
Increase (Decrease) in Accounts Receivable1,947.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities-956.00
Accrued liabilities0.00
Working capital changes0.00
Retirement benefit plans0.00
Other Working Capital-2,900.00
Other assets & liabilities0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-6,270.00
Discontinued operations0.00
Net Cash flow from Operating Activities11,130.00
Investing Activities
Capital Expenditures-2,370.00
Sale of Capital Items92.00
Short-term investments liq.0.00
Short-term investments acq.0.00
Proceeds from other investments0.00
Proceedsfromcreditsupportagreements-
Proceeds Payments From To Credit Support Agreements Investing Activities-31.00
Payments To Acquired In Process Research And Development Assets-
Payments To Acquire In Process Research And Development Assets-
Purchases of other investments0.00
Noncontrolling interest0.00
Proceeds from Investments0.00
Payments for (Proceeds from) Other Investments69.00
Purchases of non-current assets0.00
Payments to Acquire Businesses, Net of Cash Acquired-263.00
Investment in affiliate0.00
Sale of businesses0.00
Proceeds from sale of assets0.00
Note receivable0.00
Payments for (Proceeds from) Other Investing Activities-193.00
Other Net515.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-2,150.00
Financing Activities
Short-term debt Net3,469.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-2,003.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock-4,249.00
Exercise of stock options0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net-588.00
Other net1,482.00
Proceeds From Exercise Of Stock Options And Excess Tax Benefits1,172.00
Reissuance Of Common Stock-
Payments Made In Business Separation-
Dividends paid to minority interests0.00
Dividends paid-6,358.00
Net Cash Flow from Financing Activities-8,247.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow8,852.00
Total Cash Flow713.00
4 historic quarters locked

Sign in to unlock the full Johnson and Johnson cash flow history.

Sign In Create Free Account

About Johnson and Johnson Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260628)
  • Filed with the SEC: July 23, 2026
  • Source: jnj-20260628.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000200406-26-000153

Figures are derived from filed reports and may be restated. Historical data is subject to revision.